"Diabetes Mellitus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Descriptor ID |
D003920
|
| MeSH Number(s) |
C18.452.394.750 C19.246
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus".
This graph shows the total number of publications written about "Diabetes Mellitus" by people in this website by year, and whether "Diabetes Mellitus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 2 | 4 |
| 1998 | 0 | 1 | 1 |
| 1999 | 4 | 2 | 6 |
| 2000 | 1 | 0 | 1 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 4 | 6 |
| 2003 | 5 | 7 | 12 |
| 2004 | 9 | 6 | 15 |
| 2005 | 7 | 6 | 13 |
| 2006 | 4 | 3 | 7 |
| 2007 | 7 | 5 | 12 |
| 2008 | 6 | 3 | 9 |
| 2009 | 8 | 7 | 15 |
| 2010 | 9 | 5 | 14 |
| 2011 | 11 | 17 | 28 |
| 2012 | 17 | 6 | 23 |
| 2013 | 12 | 14 | 26 |
| 2014 | 11 | 14 | 25 |
| 2015 | 10 | 9 | 19 |
| 2016 | 14 | 17 | 31 |
| 2017 | 12 | 10 | 22 |
| 2018 | 16 | 6 | 22 |
| 2019 | 26 | 10 | 36 |
| 2020 | 29 | 6 | 35 |
| 2021 | 28 | 8 | 36 |
| 2022 | 68 | 1 | 69 |
| 2023 | 66 | 3 | 69 |
| 2024 | 38 | 6 | 44 |
| 2025 | 10 | 4 | 14 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus" by people in Profiles.
-
Community Participatory Co-Design and Development of a Digital Diabetes Prevention Education Program for Hispanic Families With Obesity: Mixed Methods Study. JMIR Form Res. 2026 Feb 11; 10:e67800.
-
Immune Checkpoint Inhibitor-Induced Diabetes Across National Cancer Institute Trials That Included PD-1 or PD-L1 Agents. JAMA Oncol. 2026 Feb 01; 12(2):194-199.
-
Proteomic Signatures of Cardiac Dysfunction Among People With Diabetes: The Atherosclerosis Risk in Communities Study. Circ Heart Fail. 2026 Mar; 19(3):e013171.
-
The evolving management of endocrine disorders induced by checkpoint inhibitors: insights from the CIITED group. Expert Rev Endocrinol Metab. 2026 Jan; 21(1):29-41.
-
Using Human-Centered Design and Development to Create a Digital Sick Day Medication Guidance Application for People With Diabetes, Cardiovascular Disease, or Chronic Kidney Disease: Mixed Methods Study. JMIR Form Res. 2025 Nov 27; 9:e77240.
-
Reprint of: Managing Medications During "Sick Days" in Patients With Diabetes, Kidney, and Cardiovascular Conditions: A Theory-informed Approach to Intervention Design and Implementation. Can J Diabetes. 2025 Nov; 49 Suppl 2:27-36.e4.
-
Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure. Hepatol Int. 2026 Feb; 20(1):149-162.
-
Classifying a distinct form of diabetes in lean individuals with a history of undernutrition: an international consensus statement. Lancet Glob Health. 2025 Oct; 13(10):e1771-e1776.
-
Identifying factors associated with subsequent diagnosis of adrenal adenoma: a population-based historical case-control study. Eur J Endocrinol. 2025 Aug 29; 193(3):383-390.
-
Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. Gastroenterology. 2026 Jan; 170(1):106-117.